• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[The Munster Prognosis Score (MPS)--prognostic validity of a practical instrument for prediction of progress in schizophrenic psychosis].

作者信息

Schulze Mönking H, Klingberg S

机构信息

Fachklinik für Psychiatrie, Psychotherapie und Neurologie, St. Rochus Hospital Telgte.

出版信息

Fortschr Neurol Psychiatr. 1997 Jun;65(6):243-6.

PMID:9273341
Abstract

The prognostic validity of a short and easy to handle prognostic instrument (Münster prognosis score, MPS) for schizophrenic patients is proved in this study. The MPS consists of 4 items: number of hospitalisations, stability of course of illness in the last year, premorbid development, and stability of psychosocial environment. Each item has to be rated as favourable or unfavourable. With three or four favourable ratings the prognosis is good, otherwise bad. The interrater reliability proved with 50 DSM-III schizophrenic patients had a kappa of 0.84, which is sufficient. In an 8-years follow-up with 66 DMS-III schizophrenic outpatients, the MPS had a comparably good prognostic validity according to the Strauss-Carpenter scale and the Philips scale in respect of the total symptom score (AMDP) and psychosocial functioning (GAS). According to prognosis of rehospitalisations, the MPS was as good as the SCS, and both were better than the Phillips scale.

摘要

相似文献

1
[The Munster Prognosis Score (MPS)--prognostic validity of a practical instrument for prediction of progress in schizophrenic psychosis].
Fortschr Neurol Psychiatr. 1997 Jun;65(6):243-6.
2
[The Basel Screening Instrument for Psychosis (BSIP): development, structure, reliability and validity].[巴塞尔精神病筛查工具(BSIP):开发、结构、信度和效度]
Fortschr Neurol Psychiatr. 2008 Apr;76(4):207-16. doi: 10.1055/s-2008-1038155.
3
[Disorders of premorbid social adaptation as a predictor of the 5-year prognosis of schizophrenic psychoses].病前社会适应障碍作为精神分裂症性精神病5年预后的预测指标
Nervenarzt. 1984 Jul;55(7):358-64.
4
The Calgary Depression Rating Scale for schizophrenia in a healthy control group: psychometric properties and reference values.健康对照组中用于精神分裂症的卡尔加里抑郁评定量表:心理测量特性及参考值
J Affect Disord. 2005 Sep;88(1):69-74. doi: 10.1016/j.jad.2005.04.005.
5
Prediction of symptom remission in schizophrenia during inpatient treatment.预测精神分裂症住院治疗期间的症状缓解。
World J Biol Psychiatry. 2009;10(4 Pt 2):426-34. doi: 10.1080/15622970701541054.
6
[Clinical assessment of schizophrenic syndrome (CASS): validity evaluation of the new diagnostic tool].[精神分裂症综合征的临床评估(CASS):新诊断工具的效度评估]
Psychiatr Pol. 2000 Mar-Apr;34(2):203-21.
7
[Insight in schizophrenia: assessment of 31 patients with different scales].[精神分裂症洞察:使用不同量表对31例患者进行评估]
Encephale. 2008 Jan;34(1):66-72. doi: 10.1016/j.encep.2007.01.001. Epub 2007 Sep 5.
8
[Social outcome of schizophrenics in Tunisia: a transversal study of 60 patients].[突尼斯精神分裂症患者的社会结局:对60例患者的横断面研究]
Encephale. 2009 Jun;35(3):234-40. doi: 10.1016/j.encep.2008.05.001. Epub 2008 Sep 23.
9
[Development of new prognosis indices for patients with schizophrenic diseases and evaluation of their predictive validity].[精神分裂症患者新预后指标的开发及其预测效度评估]
Fortschr Neurol Psychiatr. 1984 Dec;52(12):421-7. doi: 10.1055/s-2007-1002211.
10
Diagnostic stability over 3 years in a total group of first-episode psychosis patients.首发精神病患者全组3年的诊断稳定性。
Nord J Psychiatry. 2007;61(3):189-93. doi: 10.1080/08039480701352454.